Sterne, Kessler, Goldstein & Fox P.L.L.C.

Contact
Share
Info
1100 New York Avenue, NW
Washington, DC 20005, United States
Phone: 202.371.2600
Fax: 202.371.2540
Areas of Practice
  • Intellectual Property
  • Litigation
Locations
Other U.S. Locations
  • D.C.
Number of Attorneys
100+ Attorneys

You Can Dance If You Want To

In borrowing a page from the '80s band "Men Without Hats," on June 12, 2017, the U.S. Supreme Court brought greater certainty for both biosimilar applicants and originator companies. In Sandoz Inc. v. Amgen Inc., the Supreme…more

Amgen, Biosimilars, BPCIA, Commercial Marketing, Declaratory Relief

See all updates »

Second Chances for Secondary Considerations - Hiding the "Novelty Ball"

Like Johnny Cash’s famous tune “A Boy Named Sue,” “secondary considerations” of non-obviousness suffer for their name. Courts have historically relegated this 4th Graham factor to a “secondary” status, considering objective…more

Burden-Shifting, Graham Factors, Nexus, Nonobvious, Novelty

See all updates »

The Interface Between District Court Litigation and Contested Office Proceedings under the AIA: Motions to Stay

What is the standard for deciding a motion to stay in view of a contested office proceeding? Courts typically consider: (1) whether a stay will unduly prejudice or present a clear tactical disadvantage to the nonmoving…more

See all updates »

DMCA vs. Gearheads: Piracy Under the Shade Tree

A recent Wired magazine article by Kyle Wiens (co-founder and CEO of iFixit) provided an ominous warning to automobile owners: you don’t own your vehicle, you merely operate it at the manufacturer’s pleasure. This view of…more

Copyright, Corporate Counsel, DMCA, Popular, Young Lawyers

See all updates »

Practice Considerations Post Teva v. Sandoz

In Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., No. 13-854, slip op. 574 U.S. __ (2015), the U.S. Supreme Court ruled that underlying factual issues resolved while formally construing a disputed patent claim term at the…more

Claim Construction, De Novo Standard of Review, Extrinsic Evidence, Hatch-Waxman, Patent Litigation

See all updates »

April 1, 2017 Revision of Chinese Patent Examination Guidelines may be Good News for Patentees

With continued extraordinary growth, including a record number of patent applications filed in a single year[1], the importance of intellectual property rights in China is undeniable. And so, all eyes are on the recent revised…more

Biotechnology, Chemicals, China, Covered Business Method Patents, Patent Applications

See all updates »

Global Patent Prosecution Newsletter - November 2017

An Update on Brazilian Patent Law – Emergency Backlog/Fast-Track Options and Enforcement Issues - We are delighted to have as contributors to the November Global Patent Prosecution newsletter, Ricardo Nunes and Andre…more

Biotechnology, Brazil, Enforcement, Ex Partes Reexamination, Fast Track Process

See all updates »

USPTO Issues New Subject Matter Eligibility Examination Interim Guidelines – Nature-Based Product Guidance

On December 16, 2014, the USPTO issued a comprehensive interim Guidance document for examination of subject matter eligibility under 35 U.S.C. § 101. The new Guidance document supplements the June 2014 Preliminary Examination…more

Patent-Eligible Subject Matter, Patents, Product of Nature Doctrine, USPTO

See all updates »

Federal Circuit alters functional claiming landscape in Williamson v. Citrix Online, LLC

In Williamson v. Citrix Online, LLC, No. 2013-1130, the Federal Circuit recently overruled earlier precedent and eliminated the “strong” presumption that a functional claim limitation lacking “means” language does not invoke 35…more

America Invents Act, Appeals, Means-Plus-Function, Patent Infringement, Patent Litigation

See all updates »

Design Patent Case Digest: Ethicon Endo-Surgery, Inc. v. Covidien, Inc.

Decision Date: August 7, 2015 - Court: U.S. Court of Appeals for the Federal Circuit - Patent: D661,801; D661,802; D661,803; D661,804 - Holding: Summary judgment of invalidity REVERSED; claim construction VACATED;…more

Claim Construction, Design Patent, Medical Devices, Patent Infringement, Patent Invalidity

See all updates »

Obama Administration Releases Much Anticipated Text of the Trans-Pacific Partnership Agreement

This client alert examines intellectual property proposals in the Trans-Pacific Partnership from the perspective of biotechnology, pharmaceutical, and chemical industries. On November 5, 2015, the U.S. trade representative’s…more

Biobased Chemicals, Biologics, Biotechnology, Patent Term Adjustment, Patent Term Extensions

See all updates »

Can Digital Healthcare Innovation Be Patented? Eligibility of Digital Healthcare Technologies Under the New USPTO Eligibility Guidelines

Digital healthcare, the confluence of digital technology with medical and other biological fields, has become an ever-increasing presence in our daily lives. Ideas that seemed nearly impossible just a few years ago (such as…more

CLS Bank v Alice Corp, Digital Health, Healthcare, Interim Guidance, Medical Devices

See all updates »

Federal Circuit Supports USPTO Rules in Post-Grant Proceedings

On February 4, 2015, the Federal Circuit issued a 2-1 precedential opinion in In re Cuozzo Speed Technologies, LLC, Appeal No. 14-1301 (Fed. Cir. Feb. 4, 2014), in which it affirmed the Patent Trial and Appeal Board (PTAB) in…more

See all updates »

Federal Circuit Dismisses IPR Appeal for Lack of Standing

In Phigenix v. ImmunoGen, Appeal No. 16-1544 (Fed. Cir. Jan. 9, 2017), a precedential decision, the Federal Circuit found that the petitioner lacked standing to appeal the Patent Trial and Appeal Board’s (PTAB) final written…more

Appeals, Article III, Burden of Production, Dismissals, Injury-in-Fact

See all updates »

Pitfalls of Holiday Specific Branding

The holiday season in the United States starts around Halloween and extends for a two-month period until the beginning of January. The holiday marathon sparks a flurry of purchasing events – such as booking airline tickets,…more

Corporate Branding, Goods or Services, Holidays, Retailers, Trademark Registration

See all updates »

Patent Rights in the U.S.: Is the Pendulum Finally Swinging Back to Center?

The U.S. patent system has long struggled to strike a balance that both encourages patent rights and prevents patent abuse. Finding that balance requires giving patent owners the right amount of patent enforcement power, while…more

Abstract Ideas, America Invents Act, Burden of Persuasion, Burden of Proof, CLS Bank v Alice Corp

See all updates »

Total Profit on the Article as Sold is Alive and Well in Design Patent Litigation

Proving that damages for design patent infringement can still be significant, Columbia Sportswear Co. was awarded more than $3 million last month by a California jury in a design patent infringement lawsuit against Seirus…more

Apple v Samsung, Calculation of Damages, Damages, Design Patent, Lost Profits

See all updates »

Aglets, Who Knew?

SneakRTech Corp. wants you to defend their patent and challenge BadGuys, Incorporated’s patent at the U.S. Patent and Trademark Office Patent Trial and Appeal Board (PTAB). The subject matter: aglets…more

Aglets, Expert Testimony, Expert Witness, Patent Trial and Appeal Board, Patents

See all updates »

Fast-Tracking Patent Applications in Asia

The process of patenting an invention can be cumbersome, resulting in Applicants waiting several years before their patents are picked up for examination. Various jurisdictions have realized the pressing need to shorten the gap…more

ASEAN Patent Examination Cooperation (ASPEC) program, Asia, China, Expedited Approval Process, India

See all updates »

The Supreme Court Nixes Claims to Isolated Genomic DNA

The U.S. Supreme Court decided today that claims to isolated genomic DNA are not patentable subject matter and thus invalid. This decision rendered invalid patent claims owned by Myriad Genetics as well as thousands of patent…more

AMP v Myriad, DNA, Gene Patenting, Human Genes, Myriad

See all updates »

"Types" of Protection for Font and Typeface Designs

As a counterpoint to our article last month regarding a copyright infringement and breach of contract lawsuit filed against Target over a computer font program, we provide a brief overview of the options for protecting the IP in…more

Copyright, Design Patent, Intellectual Property Protection, Logos, Patents

See all updates »

The UK Has Spoken “Brexit” - But What Does This Mean for the IP Community?

The immediate reaction to Great Britain’s June 23, 2016 vote to leave the European Union (“EU”) (commonly referred to as “Brexit”) has been nothing short of hysterical. This paper focuses on what Brexit means for the…more

Article 50 Treaty of the EU, EU, European Patent Office, Intellectual Property Protection, IP License

See all updates »

Patent Grace Period Laws in the IP5 Patent Offices: Some Similarities But Largely Different

Life science and other high technology companies most frequently file patent applications in five IP offices (IP5), namely: the United States Patent and Trademark Office (USPTO), the European Patent Office (EPO), the Japanese…more

America Invents Act, China, EU, European Patent Office, Grace Period

See all updates »

"Retro" Designs: Using Your Utility Portfolio to Expand Design Protection

From gadgets to apparel, retro is all the rage these days. What does this mean for your consumer product patent portfolio? The obvious strategy is to consistently file design applications covering your product releases, so…more

Design Patent, Patent Portfolios, Patents, Utility Patents

See all updates »

Considerations for Developing a Global Patent Term Extension Strategy

Many jurisdictions provide for the extension of the term of the patents that cover a regulated product. Patent term extension (PTE) is particularly important in the bio/pharma industry given that development of an innovative…more

Biopharmaceutical, Generic Drugs, Global Standards, Intellectual Property Protection, Patent Prosecution

See all updates »

The Latest on Inherent Obviousness

On December 3, 2014, the Federal Circuit issued a decision in Par Pharmaceutical, Inc. and Alkermes Pharma Ireland Limited v. TWI Pharmaceuticals, Inc., agreeing with the district court’s analysis and conclusions on motivation…more

FDA, Obviousness, Patent Litigation, Patents, Pharmaceutical Patents

See all updates »

Federal Circuit panel decision 2-1 reverses U.S. International Trade Commission determination that it has authority to regulate the importation of digital data

In ClearCorrect v. ITC, issued on November 10, 2015, the Federal Circuit interpreted the term “articles” as used in Section 337 to be tangible, physical items. Accordingly, electronic transmissions were held to be outside the…more

Administrative Authority, Digital Data, Electronic Data Transmissions, Imports, Intellectual Property Protection

See all updates »

SCOTUS: Human Genes Cannot Be Patented. Is This the End or Beginning of Genetic Research?

For a Legal Perspective on today's much-anticipated U.S. Supreme Court "Myriad" decision that naturally occuring substances are not patentable, we turned to IP attorneys writing on JD Supra..…more

AMP v Myriad, Biotechnology, DNA, Healthcare, Human Genes

See all updates »

Evidence Alley: Lightweight Fabric: Admissibility versus Weight at the PTAB

Many parties in front of the Patent Trial and Appeal Board (Board) struggle with the handling of evidentiary issues. This struggle is heightened when expert evidence is the focus. In Tietex International, Ltd. v. Precision…more

Administrative Proceedings, Admissible Evidence, Declaration, Evidentiary Rulings, Expert Testimony

See all updates »

Pending Petition for CBM Review Results in Litigation Stay

The stay provisions of America Invents Act § 18(b) related to covered business method patent review1 (“CBM review”) were recently applied in Market-Alerts Pty. Ltd. v. Bloomberg Fin. L.P. et al., C.A. No. 12-780-GMS (D. Del.)…more

America Invents Act, Covered Business Method Patents, Infringement, Judicial Review, Motion To Stay

See all updates »

SCOTUS Paves the Way for Enhanced Damages with Halo Ruling

On June 13, 2016, the Supreme Court issued its opinion in Halo v. Pulse, overturning the Federal Circuit’s long-standing two-step test for willfulness and enhanced damages in patent-infringement cases. The Court’s ruling changes…more

35 U.S.C. § 284, Abuse of Discretion, Enhanced Damages, Halo v Pulse, Judicial Discretion

See all updates »

Compulsory Licensing of Biopharmaceutical Inventions

Very few topics in international intellectual property have been as controversial as compulsory licenses. While the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) sets minimum standards for…more

Biopharmaceutical, Compulsory Licenses, DOHA, Drug Pricing, Intellectual Property Protection

See all updates »

CAFC Finds Software Patent Eligible Under 35 U.S.C. §101

The Federal Circuit in Enfish LLC v. Microsoft reverses the California District Court decision that several patents related to a “self-referential” database were invalid as ineligible under 35 U.S.C. §101. Overview -…more

Abstract Ideas, CAFC, CLS Bank v Alice Corp, Microsoft, Patent Infringement

See all updates »

Recent Trends on the U.S. Doctrine of Equivalents

U.S. courts have long recognized that a product or process which does not literally infringe a patent can nevertheless infringe under the "doctrine of equivalents" if it is equivalent to the claimed invention. The percentage of…more

Appeals, Biopharmaceutical, CAFC, Doctrine of Equivalents, Enzo Biochem

See all updates »

Supreme Court to Review the Constitutionality of AIA Patent Review Proceedings

Yesterday, the Supreme Court granted certiorari in a case that may have profound implications for U.S. patent law by abolishing inter partes reviews at the U.S. Patent & Trademark Office (USPTO). In Oil States Energy…more

Administrative Proceedings, America Invents Act, Article III, Certiorari, Constitutional Challenges

See all updates »

Evidence Alley: Lightweight Fabric: Admissibility versus Weight at the PTAB

Many parties in front of the Patent Trial and Appeal Board (Board) struggle with the handling of evidentiary issues. This struggle is heightened when expert evidence is the focus. In Tietex International, Ltd. v. Precision…more

Administrative Proceedings, Admissible Evidence, Declaration, Evidentiary Rulings, Expert Testimony

See all updates »

"Types" of Protection for Font and Typeface Designs

As a counterpoint to our article last month regarding a copyright infringement and breach of contract lawsuit filed against Target over a computer font program, we provide a brief overview of the options for protecting the IP in…more

Copyright, Design Patent, Intellectual Property Protection, Logos, Patents

See all updates »

Life in the Lowercase Lane: Lessons for Trademark Owners About Genericide

Death by genericide is a painful way to go, for trademarks that is. When the public comes to think of a trademark as the common word for a product or service -- as opposed to identifying its exclusive source -- the trademark…more

Appeals, Domain Names, Genericide, Google, Trademark Infringement

See all updates »

CAFC Finds Software Patent Eligible Under 35 U.S.C. §101

The Federal Circuit in Enfish LLC v. Microsoft reverses the California District Court decision that several patents related to a “self-referential” database were invalid as ineligible under 35 U.S.C. §101. Overview -…more

Abstract Ideas, CAFC, CLS Bank v Alice Corp, Microsoft, Patent Infringement

See all updates »

Federal Circuit Clarifies the “Commercial Offer for Sale” Prong of the On-Sale Bar

On July 11, 2016, a unanimous Federal Circuit en banc affirmed that The Medicines Company’s (“TMC”) use of third-party contract manufacturing services did not invalidate U.S. Patent Nos. 7,582,727 and 7,598,343 (the…more

America Invents Act, Commercial Offer for Sale, Manufacturers, On-Sale Bar, Patent Invalidity

See all updates »

Considerations for Developing a Global Patent Term Extension Strategy

Many jurisdictions provide for the extension of the term of the patents that cover a regulated product. Patent term extension (PTE) is particularly important in the bio/pharma industry given that development of an innovative…more

Biopharmaceutical, Generic Drugs, Global Standards, Intellectual Property Protection, Patent Prosecution

See all updates »

The Supreme Court Limits What Constitutes Proper Venue

In TC Heartland LLC v. Kraft Foods Group Brands LLC, No. 16-341, 581 U.S. __ (2017), the Supreme Court reversed a Federal Circuit decision and clarified the proper scope of venue pursuant to the patent venue statute, 28 U.S.C…more

Forum Selection, Patent Infringement, Patent Litigation, Patents, Personal Jurisdiction

See all updates »

Federal Circuit panel decision 2-1 reverses U.S. International Trade Commission determination that it has authority to regulate the importation of digital data

In ClearCorrect v. ITC, issued on November 10, 2015, the Federal Circuit interpreted the term “articles” as used in Section 337 to be tangible, physical items. Accordingly, electronic transmissions were held to be outside the…more

Administrative Authority, Digital Data, Electronic Data Transmissions, Imports, Intellectual Property Protection

See all updates »

USPTO Issues New Subject Matter Eligibility Examination Guidelines for Claims Involving Laws of Nature, Natural Principles, Natural Phenomena, and/or Natural Products

On March 4, 2014, the USPTO issued a Guidance memorandum for examination of subject matter eligibility under 35 U.S.C. § 101 in view of AMP v. Myriad (2013) and Mayo v. Prometheus (2012). Under the new guidelines, the examiner…more

AMP v Myriad, Mayo v. Prometheus, Patent-Eligible Subject Matter, Patents, USPTO

See all updates »

The Supreme Court Redefines Patent Exhaustion

In Impression Products, Inc. v. Lexmark International, Inc., No. 15-1189 (U.S. May 30, 2017), the Supreme Court fundamentally changed patent licensing in the United States by eliminating a key limitation on patent exhaustion,…more

Exports, Foreign Sales, Imports, Impression Products v Lexmark International, IP License

See all updates »

Patent Term Extension Considerations for BioPharma Patents

Time spent on securing marketing approval for regulated products, such as pharmaceuticals, medical devices and agrochemicals effectively shortens the term of patent protection during which an innovator can recover its investment…more

Biopharmaceutical, FDA Approval, FFDCA, Generic Drugs, Intellectual Property Protection

See all updates »

The Board Gives Section 325(d) Sharp Teeth—Part II – The Petitioner's Criticality to Selecting and Using The Right Prior Art

This is the second of a three-part series discussing developments around Section 325(d). Part one appeared in our October 2017 newsletter and part three will appear in our December 2017 newsletter…more

America Invents Act, Ex Partes Reexamination, Follow-On Patent Petitions, Inter Partes Review (IPR) Proceeding, Obviousness

See all updates »

Energy Management Patent Triggers a Covered Business Method Review

Faced with a patent threat, renewable energy and climate change companies may have a new defense option – a Covered Business Method (CBM) proceeding. Ushered in less than 2 years ago as part of comprehensive patent reform…more

America Invents Act, Covered Business Method Proceedings, Energy Sector, Patent Royalties, Patents

See all updates »

Practical Issues for the Pharmaceutical and Biopharmaceutical Industry in the Wake of TC Heartland

The US Supreme Court this week held that the broad venue provision of 28 U.S.C. § 1391(c) does not apply to patent law—at least, when the defendant is a domestic entity. This decision arises after years of judicial…more

Biologics, Biosimilars, BPCIA, Forum Selection, Hatch-Waxman

See all updates »

Selection Invention Found Unpatentable For Obviousness-Type Double Patenting

On August 21, 2014, the Federal Circuit issued a decision in AbbVie Inc. v. The Mathilda and Terence Kennedy Institute of Rheumatology Trust., holding that the claims to a selection invention were invalid based on…more

AbbVie, Double Patent, Inventions, Obviousness, Patent Litigation

See all updates »

Defend Trade Secrets Act of 2016 - Client Advisory

This week, President Obama signed the Defend Trade Secrets Act of 2016 (DTSA) into law. Widely described as the most significant expansion of federal intellectual property law in years, the DTSA creates a new federal cause of…more

Asset Seizure, Confidentiality Agreements, Defend Trade Secrets Act (DTSA), Employer Liability Issues, Misappropriation

See all updates »

Ugh (or Ugg?), Another Trademark Dispute

UGG brand boots are a popular fixture on many holiday wish lists, but did you know that the UGG trademark has been the center of a dispute for the past decade? The comfortable sheepskin boots had a long history prior to their…more

Australia, Consumer Confusion, Corporate Branding, Generic Marks, Imports

See all updates »

A Comparison of US and EPO Post Grant Practices

Challenging the validity of a patent through the courts of Europe and the United States can be a time-consuming and expensive process. Oppositions at the European Patent Office (EPO) and US post-grant cancellation…more

Administrative Procedure, Administrative Proceedings, Amended Complaints, EU, European Patent Office

See all updates »

PTAB Issues New Standard Operating Procedure Addressing Remands from Federal Circuit: The New Standards and How They May Affect Your Remand

On November 16, 2017 the U.S. Patent and Trademark Office posted a new Standard Operating Procedure (SOP) addressing the conduct of cases remanded from the Federal Circuit to the Patent Trial and Appeal Board (PTAB). New “SOP 9”…more

Additional Discovery, Administrative Hearings, Administrative Procedure, Admissible Evidence, Appeals

See all updates »

Stratasys Extrudes Past IPR Petitions; Set to Build 3D Printer Case Against Afinia

Stratasys asserted four of its 3D printing patents against Afinia in the U.S. District Court of Minnesota. Afinia responded by petitioning for inter partes review (IPR) of the asserted patents. Yet, Stratasys escaped unscathed…more

3D Printing, Anticipation, Inter Partes Review (IPR) Proceeding, Obviousness, Patent Infringement

See all updates »

The Supreme Court Limits What Constitutes Proper Venue

In TC Heartland LLC v. Kraft Foods Group Brands LLC, No. 16-341, 581 U.S. __ (2017), the Supreme Court reversed a Federal Circuit decision and clarified the proper scope of venue pursuant to the patent venue statute, 28 U.S.C…more

Forum Selection, Patent Infringement, Patent Litigation, Patents, Personal Jurisdiction

See all updates »

PTAB Issues New Standard Operating Procedure Addressing Remands from Federal Circuit: The New Standards and How They May Affect Your Remand

On November 16, 2017 the U.S. Patent and Trademark Office posted a new Standard Operating Procedure (SOP) addressing the conduct of cases remanded from the Federal Circuit to the Patent Trial and Appeal Board (PTAB). New “SOP 9”…more

Additional Discovery, Administrative Hearings, Administrative Procedure, Admissible Evidence, Appeals

See all updates »

Federal Circuit overturns panel decision and upholds Commission in Suprema, Inc. v. International Trade Commission rehearing en banc

En banc Court reverses panel decision 6-4 and upholds U.S. International Trade Commission determination that it has broad authority to address acts of induced infringement based upon post-importation conduct. Procedural…more

Chevron Deference, Direct Infringement, En Banc Review, Imports, Induced Infringement

See all updates »

Design Patent PTO Litigation Statistics (through OCTOBER 15, 2017)

Since July 2017, there have been no new design institution decisions, and a pair of final written decisions that resulted in cancelled claims. No new design patent petitions have been filed since April 2017. The statistics below…more

Design Patent, Final Written Decisions, Inter Partes Review (IPR) Proceeding, Patent Litigation, Patents

See all updates »

The Medicines Company v. Hospira - Preparation of validation batches by a contract manufacturer for FDA submission creates an on-scale bar

On July 2, 2015, the Court of Appeals for the Federal Circuit held that a patent owner’s use of a contract manufacturer (CMO) to prepare validation batches of a drug formulation for submission to FDA created an invalidating…more

Biosimilars, FDA, Inventors, Manufacturers, Patents

See all updates »

You Can Dance If You Want To

In borrowing a page from the '80s band "Men Without Hats," on June 12, 2017, the U.S. Supreme Court brought greater certainty for both biosimilar applicants and originator companies. In Sandoz Inc. v. Amgen Inc., the Supreme…more

Amgen, Biosimilars, BPCIA, Commercial Marketing, Declaratory Relief

See all updates »

Spotlight on the Highlights -- Clarifications and Changes in the April 2016 TMEP

On April 30, 2016, the USPTO issued the April 2016 Trademark Manual of Examining Procedure ("TMEP"), the latest update to the go-to resource for how to prosecute applications to register trademarks with the USPTO. This…more

Examination Priorities, Software, Trademark Act, Trademark Registration, Trademarks

See all updates »

Patent Grace Period Laws in the IP5 Patent Offices: Some Similarities But Largely Different

Life science and other high technology companies most frequently file patent applications in five IP offices (IP5), namely: the United States Patent and Trademark Office (USPTO), the European Patent Office (EPO), the Japanese…more

America Invents Act, China, EU, European Patent Office, Grace Period

See all updates »

Federal Circuit Dismisses IPR Appeal for Lack of Standing

In Phigenix v. ImmunoGen, Appeal No. 16-1544 (Fed. Cir. Jan. 9, 2017), a precedential decision, the Federal Circuit found that the petitioner lacked standing to appeal the Patent Trial and Appeal Board’s (PTAB) final written…more

Appeals, Article III, Burden of Production, Dismissals, Injury-in-Fact

See all updates »

Federal Circuit Issues Second Reversal in an Inter Partes Review Finding the PTAB’s Obviousness Analysis to Contain “Legal Errors” Relating to Motivation to Combine

On November 3, 2015, the Federal Circuit issued Belden Inc. v. Berk-Tek LLC1, a rare precedential opinion reversing a determination by the Patent Trial and Appeal Board (PTAB) in an inter partes review proceeding. This is only…more

Appeals, Examination Procedures, Inter Partes Review (IPR) Proceeding, Obviousness, Patent Litigation

See all updates »

Pitfalls of Holiday Specific Branding

The holiday season in the United States starts around Halloween and extends for a two-month period until the beginning of January. The holiday marathon sparks a flurry of purchasing events – such as booking airline tickets,…more

Corporate Branding, Goods or Services, Holidays, Retailers, Trademark Registration

See all updates »

The Supreme Court Redefines Patent Exhaustion

In Impression Products, Inc. v. Lexmark International, Inc., No. 15-1189 (U.S. May 30, 2017), the Supreme Court fundamentally changed patent licensing in the United States by eliminating a key limitation on patent exhaustion,…more

Exports, Foreign Sales, Imports, Impression Products v Lexmark International, IP License

See all updates »

Second Chances for Secondary Considerations - Hiding the "Novelty Ball"

Like Johnny Cash’s famous tune “A Boy Named Sue,” “secondary considerations” of non-obviousness suffer for their name. Courts have historically relegated this 4th Graham factor to a “secondary” status, considering objective…more

Burden-Shifting, Graham Factors, Nexus, Nonobvious, Novelty

See all updates »

Federal Circuit issues opinion in Suprema, Inc. v. International Trade Commission

What’s at Stake? The panel majority held that exclusion orders under § 337 may not issue based on a theory of induced infringement where the direct infringement does not occur until after the articles are imported. The…more

Imports, Induced Infringement, ITC, Patent Infringement, Patents

See all updates »

The Supreme Court Heightens Antitrust Scrutiny For ANDA Reverse Payment Agreements Between Pharmaceutical Companies

The U.S. Supreme Court yesterday ruled on the long-awaited FTC v. Actavis case concerning ANDA reverse payments, resolving a sharp circuit split. The Court held that settlement agreements that include reverse payments to end…more

ANDA, Antitrust Litigation, FTC, FTC v Actavis, Patent Infringement

See all updates »

SAS Institute v. Matal, Supreme Court No. 16-969

On November 27, 2017, the Supreme Court will hear arguments in Oil States Energy Svcs, LLC v. Greene’s Energy Group, LLC, No. 16-712 where the Court will consider the constitutionality of IPR proceedings. The Oil States case has…more

Administrative Procedure, Chevron Deference, Final Written Decisions, Inter Partes Review (IPR) Proceeding, Patent Trial and Appeal Board

See all updates »

Federal Circuit panel decision 2-1 reverses U.S. International Trade Commission determination that it has authority to regulate the importation of digital data

In ClearCorrect v. ITC, issued on November 10, 2015, the Federal Circuit interpreted the term “articles” as used in Section 337 to be tangible, physical items. Accordingly, electronic transmissions were held to be outside the…more

Administrative Authority, Digital Data, Electronic Data Transmissions, Imports, Intellectual Property Protection

See all updates »

This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.